11A
JNJ icon

10-15 Associates’s Johnson & Johnson JNJ Stock Holding History

10-15 Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$15.7M Sell
105,623
-20,040
-16% -$2.97M 3.05% 5
2020
Q2 		$17.7M Buy
125,663
+2,359
+2% +$344K 3.56% 3
2020
Q1 		$16.2M Buy
123,304
+5,733
+5% +$813K 3.77% 3
2019
Q4 		$17.1M Buy
117,571
+1,816
+2% +$246K 3.24% 5
2019
Q3 		$15M Buy
115,755
+1,606
+1% +$212K 3.08% 6
2019
Q2 		$15.9M Buy
114,149
+1,948
+2% +$270K 3.45% 3
2019
Q1 		$15.7M Buy
112,201
+881
+0.8% +$118K 3.37% 4
2018
Q4 		$14.4M Buy
111,320
+681
+0.6% +$95K 3.51% 6
2018
Q3 		$15.3M Sell
110,639
-2,773
-2% -$368K 3.42% 4
2018
Q2 		$13.8M Buy
113,412
+2,007
+2% +$250K 3.09% 4
2018
Q1 		$14.3M Buy
111,405
+4,280
+4% +$579K 3.39% 4
2017
Q4 		$15M Sell
107,125
-1,159
-1% -$161K 3.58% 4
2017
Q3 		$14.1M Sell
108,284
-701
-0.6% -$92.9K 3.56% 2
2017
Q2 		$14.4M Sell
108,985
-927
-0.8% -$118K 4.05% 3
2017
Q1 		$13.7M Buy
109,912
+2,052
+2% +$245K 3.75% 3
2016
Q4 		$12.4M Buy
107,860
+6,738
+7% +$778K 3.49% 4
2016
Q3 		$11.9M Sell
101,122
-1,334
-1% -$162K 3.32% 3
2016
Q2 		$12.4M Sell
102,456
-1,675
-2% -$190K 3.57% 2
2016
Q1 		$11.3M Sell
104,131
-21,329
-17% -$2.21M 3.51% 2
2015
Q4 		$12.9M Buy
125,460
+4,911
+4% +$494K 3.75% 3
2015
Q3 		$11.3M Buy
120,549
+5,333
+5% +$516K 3.86% 2
2015
Q2 		$11.2M Buy
115,216
+15,653
+16% +$1.57M 3.48% 4
2015
Q1 		$10M Buy
99,563
+18,996
+24% +$1.93M 3.35% 6
2014
Q4 		$8.42M Sell
80,567
-1,077
-1% -$113K 2.7% 10
2014
Q3 		$8.7M Buy
81,644
+869
+1% +$90.1K 2.93% 10
2014
Q2 		$8.45M Sell
80,775
-18,089
-18% -$1.83M 2.68% 13
2014
Q1 		$9.71M Sell
98,864
-151
-0.2% -$14K 3.17% 6
2013
Q4 		$9.07M Sell
99,015
-362
-0.4% -$33.4K 3.11% 8
2013
Q3 		$8.62M Sell
99,377
-13,303
-12% -$1.19M 3.58% 8
2013
Q2 		$9.68M Buy
+112,680
New +$9.56M 4.46% 3

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

10-15 Associates's JNJ Position: Q3 2020 in Review

10-15 Associates reduced its Johnson & Johnson (JNJ) stake by 16% in Q3 2020, selling an estimated $2.97M and leaving 105,623 shares worth $15.7M. The position accounts for 3.05% of the portfolio, ranked #5.

10-15 Associates first reported a position in JNJ in Q2 2013 and has held it in 30 quarters since. The position peaked at $17.7M in Q2 2020. 2,985 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • 10-15 Associates held 105,623 shares of Johnson & Johnson worth $15.7M as of Q3 2020.
  • 10-15 Associates sold 20,040 Johnson & Johnson shares in Q3 2020, an estimated $2.97M.
  • Johnson & Johnson made up 3.05% of 10-15 Associates's portfolio in Q3 2020, its #5 holding.
  • 10-15 Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 30 quarters since.
  • 10-15 Associates's Johnson & Johnson position peaked at $17.7M in Q2 2020.
  • 2,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.